Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
NANO MRNA, Continue Net Income Turns to Loss
4571 NANO MRNA Co., Ltd. 【J-GAAP】
Earnings ReportNANO MRNA Co., Ltd. <4571> [TSE Growth] announced its financial results after the market closed on May 14th (15:30). The consolidated net loss for the fiscal year ending March 2025 expanded to a loss of 835 million yen (compared to a loss of 780 million yen in the previous period). For the fiscal year ending March 2026, the consolidated net loss is nearly flat with a slight increase of loss of 860 million yen. This will mark the 24th consecutive term of losses.
In the most recent three-month period, from January to March (4Q), the consolidated net loss expanded to a loss of 240 million yen (compared to a loss of 43 million yen in the same period last year). The operating profit/loss margin drastically worsened from -571.0% in the same period last year to -1080.0%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2023 | 202 | -1,246 | -1,104 | -1,310 | -18.7 | 0 | May 12, 2023 | J-GAAP |
| Mar, 2024 | 135 | -864 | -749 | -780 | -11.1 | 0 | May 14, 2024 | J-GAAP |
| Mar, 2025 | 108 | -755 | -687 | -835 | -11.9 | 0 | May 14, 2025 | J-GAAP |
| YoY | -20.0% | +12.6% | +8.3% | -7.1% | -6.8% |
Full Year Results vs. Previous Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2025 Guidance | 108 | -893 | -856 | -994 | -14.1 | 0 | Nov 14, 2024 | J-GAAP |
| Mar, 2025 Results | 108 | -755 | -687 | -835 | -11.9 | 0 | May 14, 2025 | J-GAAP |
| Revision Rate | 0.0% | +15.5% | +19.7% | +16.0% | +15.8% |
Current Period Guidance
H1 Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Sep, 2024 | 7 | -373 | -382 | -518 | -7.4 | 0 | Nov 14, 2024 | J-GAAP |
| Apr - Sep, 2025 Guidance | ー | ー | ー | ー | - | 0 | May 14, 2025 | J-GAAP |
| YoY | - | - | - | - | - |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2024 | 135 | -864 | -749 | -780 | -11.1 | 0 | May 14, 2024 | J-GAAP |
| Mar, 2025 | 108 | -755 | -687 | -835 | -11.9 | 0 | May 14, 2025 | J-GAAP |
| Mar, 2026 Guidance | 75 | -966 | -856 | -860 | -12.0 | 0 | May 14, 2025 | J-GAAP |
| YoY | -30.6% | -27.9% | -24.6% | -3.0% | -0.8% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Mar, 2024 | 31 | -177 | -86 | -43 | -0.6 | -571.0 | May 14, 2024 | J-GAAP |
| Apr - Jun, 2024 | 0 | -189 | -155 | -156 | -2.2 | -Inf | Aug 9, 2024 | J-GAAP |
| Jul - Sep, 2024 | 7 | -184 | -227 | -362 | -5.1 | -2,628.6 | Nov 14, 2024 | J-GAAP |
| Oct - Dec, 2024 | 76 | -112 | -64 | -77 | -1.1 | -147.4 | Feb 14, 2025 | J-GAAP |
| Jan - Mar, 2025 | 25 | -270 | -241 | -240 | -3.4 | -1,080.0 | May 14, 2025 | J-GAAP |
| YoY | -19.4% | -52.5% | -180.2% | -458.1% | -459.0% |
Related Articles
Solasia Pharma, Jan-Mar (1Q) Net Income Loss Narrows
Harmonic Drive Systems, 74% Decrease in Ordinary Profit for the Last Fiscal Year, Current period performance is undisclosed.
AnyMind Group, The Current Fiscal Year Net Income Revised Downward to an Unexpected 61% Decrease, The Undetermined Dividend Revised to 2 yen
KIMURATAN, 16 times Increase in Ordinary Profit for The Current Fiscal Year
YAMAKI, Last Fiscal Year Ordinary Profit Revised Downward by 40%
Tokyo Century, 9% Increase in Net Income, Update Record High for Third Consecutive Term, Increased Previous Year's Dividend by 4 yen, This Fiscal Year to Increase Dividend by 6 yen
NIPPON PAINT, Jan-Mar (1Q) Net Income Increases by 26%
Branding Tech, Last Fiscal Year's Ordinary Profit Exceeds Expectations, 9% Increase in Ordinary Profit for The Current Fiscal Year
SYNCLAYER, Jan-Mar (1Q) Ordinary Profit Increases by 2%
ACSL, Jan-Mar (1Q) Ordinary Profit Loss Narrows